VI
RPRX icon

Vestcor Inc’s Royalty Pharma RPRX Stock Holding History

Vestcor Inc’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$386K Hold
8,044
– – 0.01% 826
2025
Q4 		$311K Hold
8,044
– – 0.01% 869
2025
Q3 		$284K Hold
8,044
– – 0.01% 897
2025
Q2 		$290K Sell
8,044
-37
-0.5% -$1.23K 0.01% 883
2025
Q1 		$252K Hold
8,081
– – 0.01% 905
2024
Q4 		$206K Hold
8,081
– – 0.01% 979
2024
Q3 		$229K Hold
8,081
– – 0.01% 935
2024
Q2 		$213K Hold
8,081
– – 0.01% 927
2024
Q1 		$245K Sell
8,081
-59
-0.7% -$1.74K 0.01% 889
2023
Q4 		$229K Sell
8,140
-80
-1% -$2.2K 0.01% 949
2023
Q3 		$223K Hold
8,220
– – 0.01% 946
2023
Q2 		$253K Sell
8,220
-73
-0.9% -$2.47K 0.01% 777
2023
Q1 		$299K Hold
8,293
– – 0.01% 768
2022
Q4 		$328K Buy
8,293
+90
+1% +$3.76K 0.01% 771
2022
Q3 		$330K Buy
8,203
+145
+2% +$6.19K 0.01% 788
2022
Q2 		$339K Buy
8,058
+2,624
+48% +$108K 0.01% 784
2022
Q1 		$212K Buy
5,434
+1,218
+29% +$47.8K 0.01% 917
2021
Q4 		$168K Buy
4,216
+1,602
+61% +$62.2K 0.01% 912
2021
Q3 		$94K Sell
2,614
-317
-11% -$12.3K ﹤0.01% 1010
2021
Q2 		$120K Buy
+2,931
New +$125K ﹤0.01% 1008

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vestcor Inc's RPRX Position: Q1 2026 in Review

Vestcor Inc held its Royalty Pharma (RPRX) position steady in Q1 2026 at 8,044 shares worth $386K. The position accounts for 0.01% of the portfolio, ranked #826.

Vestcor Inc first reported a position in RPRX in Q2 2021 and has held it in 20 quarters since. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Vestcor Inc held 8,044 shares of Royalty Pharma worth $386K as of Q1 2026.
  • Vestcor Inc left its Royalty Pharma share count unchanged in Q1 2026.
  • Royalty Pharma made up 0.01% of Vestcor Inc's portfolio in Q1 2026, its #826 holding.
  • Vestcor Inc first reported a position in Royalty Pharma in Q2 2021 and has held it in 20 quarters since.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.